|
"liou jp"的相關文件
顯示項目 106-130 / 136 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2007-10 |
A novel oral indoline-sulfonamide agent, N-[1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-Isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
|
Liou, JP; Hsu, KS; Kuo, CC; Chang, CY; Chang, JY |
| 國家衛生研究院 |
2007-09-06 |
4-and 5-aroylindoles as novel classes of potent antitubulin agents
|
Liou, JP; Wu, CY; Hsieh, HP; Chang, CY; Chen, CM; Kuo, CC; Chang, JY |
| 國家衛生研究院 |
2007-07 |
A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule
|
Chang, JY;Liou, JP |
| 臺北醫學大學 |
2007 |
2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
|
劉景平; Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chi |
| 臺北醫學大學 |
2007 |
4- and 5-Aroylindoles as Novel Classes of Potent Antitubulin Agents.
|
劉景平; Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY |
| 臺北醫學大學 |
2007 |
A novel oral indoline-sulfonamide agent; J30; exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
|
劉景平; Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY; |
| 臺北醫學大學 |
2007 |
Combretastatin A-4 Induced Differential Cytotoxicity and Reduced Metastatic Ability by Inhibition of AKT Function in Hunan Gastric Cancer Cells.
|
劉景平; Lin HL; Chiou SH; Wu CW; Lin WB; Chen LH; Yang YP; Tsai ML; Uen YH; Liou JP; Chi CW |
| 國家衛生研究院 |
2006-11-16 |
7-aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents
|
Chang, JY; Hsieh, HP; Chang, CY; Hsu, KS; Chiang, YF; Chen, CM; Kuo, CC; Liou, JP |
| 國家衛生研究院 |
2006-10-19 |
2-amino and 2 '-aminocombretastatin derivatives as potent antimitotic agents
|
Chang, JY; Yang, MF; Chang, CY; Chen, CM; Kuo, CC; Liou, JP |
| 國家衛生研究院 |
2006-10 |
Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents
|
Liou, JP;Mahindroo, N;Chang, CW;Guo, FM;Lee, SWH;Tan, UK;Yeh, TK;Kuo, CC;Chang, YW;Lu, PH;Tung, YS;Lin, KT;Chang, JY;Hsieh, HP |
| 國家衛生研究院 |
2006-05 |
Antitubulin agents for the treatment of cancer - a medicinal chemistry update
|
Mahindroo, N; Liou, JP; Chang, JY; Hsieh, HP |
| 臺北醫學大學 |
2006 |
2-Amino and 2’-Aminocombretastatin Derivatives as Potential Antimitotic Agent
|
陳繼明; 劉景平; Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP |
| 臺北醫學大學 |
2006 |
7-Aroyl-aminoindoline-1-sulfonamides as a Novel Class of Potent Antitubulin Agents
|
劉景平; 陳繼明; Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP* |
| 臺北醫學大學 |
2006 |
Antitubulin agents for the treatment of cancer-a medicinal chemistry update
|
劉景平; Mahindroo N; Liou JP; Chang JY; Hsieh HP |
| 臺北醫學大學 |
2006 |
Structure-Activity Relationship Studies of 3-Aroylindoles as Potent Antimitotic Agents
|
劉景平; Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Yeh TK; Tan UK; Kuo CC; Chang YW; Lu PH; Tung YS; |
| 國家衛生研究院 |
2005-08-23 |
Indole compounds
|
Hsieh, HP;Liou, JP;Chang, JY;Chang, CW |
| 國家衛生研究院 |
2005-05 |
Pharmaceutical design of antimitotic agents based on combretastatins
|
Hsieh, HP;Liou, JP;Mahindroo, N |
| 臺北醫學大學 |
2005 |
A concise synthesis of denbinobin
|
陳繼明; 劉景平; Wang YC; Lin CH; Chen CM; Liou JP |
| 臺北醫學大學 |
2005 |
A concise synthesis of denbinobin.
|
林建煌; Wang YC; Lin CH; Chen CM; Liou JP |
| 國家衛生研究院 |
2004-09 |
Drug design of BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;Chang, CW;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 國家衛生研究院 |
2004-08-22 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents
|
Hsieh, HP;Liou, JP;Chang, YL;Lee, SJ |
| 國家衛生研究院 |
2004-08-12 |
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents
|
Liou, JP; Chang, YL; Kuo, FM; Chang, CW; Tseng, HY; Wang, CC; Yang, YN; Chang, JY; Lee, SJ; Hsieh, HP |
| 國家衛生研究院 |
2004-07-15 |
A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells
|
Juang, SH; Pan, WY; Kuo, CC; Liou, JP; Hung, YM; Chen, LT; Hsieh, HP; Chang, JY |
| 國家衛生研究院 |
2004-07 |
Drug design for BPR0L075 as an anticancer agent
|
Hsieh, HP;Liou, JP;W., CC;Kuo, CC;Chang, YL;Kuo, FM;Tseng, HY;Pan, WY;Chen, CP;Yang, YN;Chen, CT;Lee, SJ;Chang, JY |
| 國家衛生研究院 |
2004-05-20 |
Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents
|
Liou, JP; Chang, JY; Chang, CW; Chang, CY; Mahindroo, N; Kuo, FM; Hsieh, HP |
顯示項目 106-130 / 136 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
